These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 10422888)
1. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats. Sánchez C; Mørk A Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888 [TBL] [Abstract][Full Text] [Related]
2. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain. Vinod KY; Subhash MN; Srinivas BN Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737 [TBL] [Abstract][Full Text] [Related]
3. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates. Alper RH; Nelson DL Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708 [TBL] [Abstract][Full Text] [Related]
5. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors. Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS; Assié MB; Koek W J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys. Winsauer PJ; Moerschbaecher JM Behav Pharmacol; 2000 Nov; 11(7-8):535-53. PubMed ID: 11198126 [TBL] [Abstract][Full Text] [Related]
8. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors. Clarke RW; Ogilvie J; Houghton AK Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958 [TBL] [Abstract][Full Text] [Related]
9. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain. Tilakaratne N; Friedman E Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223 [TBL] [Abstract][Full Text] [Related]
10. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Yocca FD; Iben L; Meller E Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034 [TBL] [Abstract][Full Text] [Related]
11. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats. Koek W; Assié MB; Zernig G; France CP Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965 [TBL] [Abstract][Full Text] [Related]
13. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis. Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat. Bagdy G; Kalogeras KT Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526 [TBL] [Abstract][Full Text] [Related]
15. Further characterization of 5-HT1A receptors in the goldfish retina: role of cyclic AMP in the regulation of the in vitro outgrowth of retinal explants. Schmeer C; Obregón F; Urbina M; Lima L Neurochem Res; 2001 Mar; 26(3):213-23. PubMed ID: 11495544 [TBL] [Abstract][Full Text] [Related]
16. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Meller E; Goldstein M; Bohmaker K Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223 [TBL] [Abstract][Full Text] [Related]
17. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ. Keck BJ; Lakoski JM Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365 [TBL] [Abstract][Full Text] [Related]
18. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471 [TBL] [Abstract][Full Text] [Related]
19. Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones. Meller E; Bohmaker K J Pharmacol Exp Ther; 1994 Dec; 271(3):1246-52. PubMed ID: 7996433 [TBL] [Abstract][Full Text] [Related]
20. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats. Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]